Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction.
about
Supraventricular tachycardia presenting in labour: A case report achieving vaginal birth and review of the literature.Maternal arrhythmia and perinatal outcomes.Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de EstimulacióUse of medication for cardiovascular disease during pregnancy.Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Pediatric Cardiology (SICP), and Italian Society of Gynaecologists and Obstetrics (SIGO): pregnancy and congenital heart diseases.Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3β pathway.European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca yConcurrent maternal and fetal tachyarrhythmia in pregnancy.Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study).
P2860
Q37107269-ED493B69-6F94-4507-80F0-288DB5C5298BQ37302653-6E44030E-021F-4BCF-BAC6-A2D4A7F4BA5FQ37596058-311012DF-45D1-44D3-8CB8-0B3917B415F7Q38639052-1A624866-42B9-4FDE-85D8-8E48665FD69AQ38875036-31DFB0B2-0DF7-4F04-8112-EC780CAA1D09Q41118476-6D97D816-482B-4422-AD96-B0DDE3A158BBQ46031696-F818068C-5F3D-438F-BCCC-424E70792238Q48032949-B7482ED9-8B2F-4533-8E10-F853AAC4B89FQ49961628-7C54336F-03C6-49C2-AFED-3ED5263B48A4Q55002875-9B873A53-50AB-4B3C-ADDB-AB5A03696FE0
P2860
Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Treatment with oral beta-block ...... k of fetal growth restriction.
@en
Treatment with oral beta-block ...... k of fetal growth restriction.
@nl
type
label
Treatment with oral beta-block ...... k of fetal growth restriction.
@en
Treatment with oral beta-block ...... k of fetal growth restriction.
@nl
prefLabel
Treatment with oral beta-block ...... k of fetal growth restriction.
@en
Treatment with oral beta-block ...... k of fetal growth restriction.
@nl
P2093
P2860
P356
P1476
Treatment with oral beta-block ...... k of fetal growth restriction.
@en
P2093
A S Ersbøll
L Søndergaard
M Hedegaard
M Johansen
P2860
P304
P356
10.1111/1471-0528.12522
P577
2014-01-09T00:00:00Z